Skip to main content
Arsham Sheybani, MD, Ophthalmology, St. Louis, MO

Arsham Sheybani MD

Anterior Segment Related, Cataract Related, Glaucoma Related


Associate Professor, Ophthalmology & Visual Sciences, Washington University in St. Louis School of Medicine Residency Program Director; Fellowship Director, Glaucoma and Anterior Segment Surgery

Join to view full profile
  • 4901 Forest Park AveFl 6St. Louis, MO 63108

  • Phone+1 314-362-3937

  • Fax+1 314-362-3725

Dr. Sheybani is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2009 - 2012
  • Mercy Hospital (St Louis)
    Mercy Hospital (St Louis)Internship, Transitional Year, 2008 - 2009
  • WashU Medicine
    WashU MedicineClass of 2008

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2012 - 2027
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2013, 2015-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013, 2015-2017
  • CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2013, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Authored Content

  • Low Blood Pressure Is a Significant Risk Factor for Developing Incident OAGDecember 2022
  • Nearly 20% of Glaucoma Surgeries for POAG Fail After 5 YearsFebruary 2022

Press Mentions

  • A Database Study Finds Less Risk of CME with Prostaglandin Analogs Than with Other Topical Drugs
    A Database Study Finds Less Risk of CME with Prostaglandin Analogs Than with Other Topical DrugsMay 26th, 2026
  • Streamlining Combined Cataract-Glaucoma Treatment
    Streamlining Combined Cataract-Glaucoma TreatmentSeptember 26th, 2025
  • Iantrek Expands Clinical Evidence for AlloFlo Uveo with Two New Peer-Reviewed Publications
    Iantrek Expands Clinical Evidence for AlloFlo Uveo with Two New Peer-Reviewed PublicationsFebruary 9th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: